NCT07909031: CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 219 planned
- Started
- 21 Oct 2026
- Primary completion
- Oct 2028
- Arms
- CR-002 Dose Escalation, CR-002 Backfill
- Results
- None posted
- 21 Oct 2026: Trial started
- 2 Nov 2026: Trial registered